Ivanode 5 Tablet contains Ivabradine 5 mg, a selective sinus node inhibitor used primarily for the management of chronic stable angina pectoris and heart failure. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, leading to heart rate reduction without affecting myocardial contractility or intracardiac conduction. This mechanism helps decrease myocardial oxygen demand and improves exercise tolerance in patients with angina. Ivanode 5 is indicated for patients with stable angina who are in sinus rhythm with a resting heart rate of at least 70 beats per minute and who are intolerant to or inadequately controlled by beta-blockers. Additionally, it is prescribed for symptomatic chronic heart failure patients with left ventricular systolic dysfunction and a resting heart rate above 70 bpm, in conjunction with standard therapy including beta-blockers, ACE inhibitors, or diuretics. The recommended dosage should be individualized based on heart rate response and clinical condition, with careful monitoring to avoid bradycardia. Common adverse effects include luminous phenomena, bradycardia, and headache. Ivanode 5 should be used cautiously in patients with conduction abnormalities and contraindicated in acute decompensated heart failure, severe hypotension, and pacemaker dependence.